Inspire Medical Systems (INSP) EBITDA (2017 - 2026)

Inspire Medical Systems' EBITDA history runs 10 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• In Q1 2026, EBITDA fell 141.67% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $141.5 million (up 112.51% YoY), while the FY2025 annual figure was $145.4 million, up 172.98% from the prior year.
• EBITDA came in at -$1.1 million for Q1 2026 at Inspire Medical Systems, down from $135.9 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $135.9 million in Q4 2025 to a low of -$17.0 million in Q3 2022.
• A 5-year average of $7.8 million and a median of -$1.1 million in 2026 frame the typical range for EBITDA.
• Across the five-year window, EBITDA surged 352.85% in 2023 and plunged 141.67% in 2026, its largest moves.
• Inspire Medical Systems' EBITDA stood at $3.4 million in 2022, then jumped by 352.85% to $15.5 million in 2023, then soared by 119.47% to $34.1 million in 2024, then surged by 299.05% to $135.9 million in 2025, then plunged by 100.82% to -$1.1 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$1.1 million, $135.9 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison